CompletedNot Applicable

"Validity and Reliability of Pelvic Floor Distress Inventory-20 in Primary Sjögren's Syndrome"

Turkey (Türkiye)10 participantsStarted 2025-03-28

Plain-language summary

The aim of this study is to examine the Turkish validity and reliability of the Pelvic Floor Distress Inventory-20 in patients with pSS.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being diagnosed with Primary Sjögren's Syndrome by the PAÜ Rheumatology clinic * Being between the ages of 18 and 65 * Volunteering to participate in the study Exclusion Criteria: * Presence of neurological disease * Presence of any orthopedic problem that may affect functionality * History of orthopedic surgery * Presence of psychiatric disorder that may affect cooperation

What they're measuring

EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)

Timeframe: Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.

Pelvic Floor Distress Inventory-20 (PTDE-20)

Timeframe: Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.

Visual Analog Scale (VAS)

Timeframe: Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period.

Trial details

NCT IDNCT07248436

SponsorPamukkale University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-05-28

View on ClinicalTrials.gov More Sjogren Syndrome trials